OTCMKTS:THERF - Theratechnologies Stock Price, News, & Analysis

$5.41
-0.08 (-1.46 %)
(As of 06/25/2019 08:35 AM ET)
Today's Range
$5.36
Now: $5.41
$5.50
50-Day Range
$4.20
MA: $4.93
$5.7056
52-Week Range
$3.85
Now: $5.41
$10.0364
Volume18,344 shs
Average Volume43,855 shs
Market Capitalization$416.30 million
P/E RatioN/A
Dividend YieldN/A
Beta0.55
Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:THERF
Previous SymbolNASDAQ:THER
CUSIPN/A
CIKN/A
Phone514-336-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$45.18 million
Cash Flow$0.0202 per share
Book Value$0.47 per share

Profitability

Net Income$-4,660,000.00

Miscellaneous

Employees32
Market Cap$416.30 million
Next Earnings Date7/4/2019 (Estimated)
OptionableNot Optionable

Receive THERF News and Ratings via Email

Sign-up to receive the latest news and ratings for THERF and its competitors with MarketBeat's FREE daily newsletter.

Theratechnologies (OTCMKTS:THERF) Frequently Asked Questions

What is Theratechnologies' stock symbol?

Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF."

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc (OTCMKTS:THERF) posted its quarterly earnings results on Thursday, April, 4th. The company reported $0.01 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.01. The firm had revenue of $15.10 million for the quarter. Theratechnologies had a negative net margin of 7.38% and a negative return on equity of 1.31%. View Theratechnologies' Earnings History.

When is Theratechnologies' next earnings date?

Theratechnologies is scheduled to release their next quarterly earnings announcement on Thursday, July 4th 2019. View Earnings Estimates for Theratechnologies.

What is the consensus analysts' recommendation for Theratechnologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Theratechnologies.

Has Theratechnologies been receiving favorable news coverage?

Media headlines about THERF stock have been trending extremely negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Theratechnologies earned a coverage optimism score of -4.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Theratechnologies.

Who are some of Theratechnologies' key competitors?

What other stocks do shareholders of Theratechnologies own?

Who are Theratechnologies' key executives?

Theratechnologies' management team includes the folowing people:
  • Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)
  • Mr. Philippe Dubuc MBA, Sr. VP & CFO (Age 52)
  • Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)
  • Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53)
  • Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)

How do I buy shares of Theratechnologies?

Shares of THERF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Theratechnologies' stock price today?

One share of THERF stock can currently be purchased for approximately $5.41.

How big of a company is Theratechnologies?

Theratechnologies has a market capitalization of $416.30 million and generates $45.18 million in revenue each year. Theratechnologies employs 32 workers across the globe.View Additional Information About Theratechnologies.

What is Theratechnologies' official website?

The official website for Theratechnologies is http://www.theratech.com/.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The company can be reached via phone at 514-336-7800 or via email at [email protected]


MarketBeat Community Rating for Theratechnologies (OTCMKTS THERF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  68 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  137
MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote "Outperform" if you believe THERF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THERF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel